Qiang Kang

BGI Group (China) — China

Medicine · Health Sciences

24h-index1.7kcitations109works7.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies(15), Cancer-related molecular mechanisms research(14), Single-cell and spatial transcriptomics(13), Nanoplatforms for cancer theranostics(10), Cancer-related gene regulation(9)

Publications109 total

MicroGenomer: A Foundation Model for Transferable Microbial Genome Representations Enabling Multi-scale Genomic Understanding and Ecophysiological Trait Prediction
2025Open Access
S···O Conformation Locks Synergistic Alkoxy Chain Engineering of NIR‐II Phototheranostic Molecules for Precision Hepatocellular Carcinoma Theranostics
Advanced Science·2025Open Access
CellBin:a generalist framework to process spatial omics data to cell level
2025Open Access
1 MeV Electron Irradiation Effect and Damage Mechanism Analysis of GaInP/GaAs Heterojunction Solar Cells
Chinese Physics B·2025Open Access
Prediction of soil probiotics based on foundation model representation enhancement and stacked aggregation classifier
Briefings in Bioinformatics·2025Open Access
Unimolecular Micellization Strategy for Achieving NIR-II Excited Fluorophores with Enhanced Brightness in Aqueous
2025Open Access
Prediction of soil probiotics based on foundation model representation enhancement and stacked aggregation classifier
2025
Intelligent Materials Science for the Future
Bulletin of National Natural Science Foundation of China·2025Open Access
Stereopy: modeling comparative and spatiotemporal cellular heterogeneity via multi-sample spatial transcriptomics
Nature Communications·2025· 23 citedOpen Access
Molecular Engineering of NIR-II Excitable Phototheranostic for Mitochondria-Targeted Cancer Photoimmunotherapy
Journal of Medicinal Chemistry·2025· 5 cited
Rationally designed NIR-II excitable and endoplasmic reticulum-targeted molecular phototheranostics for imaging-guided enhanced photoimmunotherapy of triple-negative breast cancer
Journal of Nanobiotechnology·2025· 5 citedOpen Access
Conversion therapy strategy: A novel GPC3-targeted multimodal organic phototheranostics platform for mid-late-stage hepatocellular carcinoma
Materials Today Bio·2025· 4 citedOpen Access
CellBinDB: a large-scale multimodal annotated dataset for cell segmentation with benchmarking of universal models
GigaScience·2025· 3 citedOpen Access
Bioorthogonal Engineering of Bacterial Outer Membrane Vesicles for NIR-II Fluorescence Imaging-Guided Synergistic Enhanced Immunotherapy
Analytical Chemistry·2024· 16 cited
CellBinDB: A Large-Scale Multimodal Annotated Dataset for Cell Segmentation with Benchmarking of Universal Models
2024· 2 citedOpen Access
Conversion Therapy Strategy: A Novel GPC3-Targeted Multimodal Organic Phototheranostics Platform for Mid-late-stage Hepatocellular Carcinoma
2024· 1 citedOpen Access
A large-cell neuroendocrine carcinoma in the extrahepatic bile duct: A case report and literature review
Asian Journal of Surgery·2024· 2 citedOpen Access
Multi-omics integration for both single-cell and spatially resolved data based on dual-path graph attention auto-encoder
Briefings in Bioinformatics·2024· 18 citedOpen Access
[Effect of deletion of protein 4.1R on proliferation, apoptosis and glycolysis of hepatocyte HL-7702 cells].
PubMed·2024Open Access
Portal Venous and Hepatic Arterial Coefficients Predict Post-Hepatectomy Overall and Recurrence-Free Survival in Patients with Hepatocellular Carcinoma: A Retrospective Study
Journal of Hepatocellular Carcinoma·2024· 92 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Hao Zou(9), Zhongwu Li(7), Xiaozheng Huang(7), Jun Meng(7), Lixin Liu(6), Yushi Luan(6), Lixin Zhou(5), Nan Xie(5), Jiabin Cai(5), Xia Wang(4), Li Sun(4), Lin Jia(4), Ai‐Wu Ke(4), Gui‐long Wu(4), Na Li(4), Sha Yang(4), Xiaofeng Tan(4), Qinglai Yang(4), Dongfeng Niu(4), Dengfeng Cao(4)